|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/48 | |
| A61P 25/02 |
| (11) | Number of the document | 2280719 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09734803.1 |
| Date of filing the European patent application | 2009-04-27 | |
| (97) | Date of publication of the European application | 2011-02-09 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2009/005750 |
| Date | 2009-04-27 |
| (87) | Number | WO 2009/130600 |
| Date | 2009-10-29 |
| (30) | Number | Date | Country code |
| 0802321 | 2008-04-25 | FR |
| (72) |
FAVRE, Christine, FR
AUGUET, Michel, FR
CHABRIER DE LASSAUNIERE, Pierre-Etienne, FR
|
| (73) |
IPSEN PHARMA S.A.S.,
65, Quai Georges Gorse, 92100 Boulogne-Billancourt,
FR
|
| (54) | THERAPEUTIC USE OF BOTULINUM NEUROTOXIN TYPE A IN THE TREATMENT OF PAIN ASSOCIATED WITH DIABETIC NEUROPATHY |
| THERAPEUTIC USE OF BOTULINUM NEUROTOXIN TYPE A IN THE TREATMENT OF PAIN ASSOCIATED WITH DIABETIC NEUROPATHY |